STOCK TITAN

[8-K] Bausch & Lomb Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Bausch + Lomb Corporation furnished an 8-K announcing results of operations for the quarter ended September 30, 2025. The detailed financial information is provided in a press release attached as Exhibit 99.1.

The Item 2.02 information is being furnished and is not deemed filed under the Exchange Act, and it is not incorporated by reference into Securities Act filings. The company’s common shares trade as BLCO on the NYSE and Toronto Stock Exchange.

Bausch + Lomb Corporation ha fornito un 8-K che annuncia i risultati operativi per il trimestre chiuso il 30 settembre 2025. Le informazioni finanziarie dettagliate sono fornite in un comunicato stampa allegato come Exhibit 99.1.

Le informazioni dell'Item 2.02 vengono fornite e non si ritengono presentate ai sensi della Exchange Act, e non sono incorporate per riferimento nei filing ai sensi del Securities Act. Le azioni ordinarie della società sono negoziate con il simbolo BLCO sulla NYSE e sulla Toronto Stock Exchange.

La Bausch + Lomb Corporation presentó un 8-K anunciando los resultados de operaciones para el trimestre terminado el 30 de septiembre de 2025. La información financiera detallada se ofrece en un comunicado de prensa adjunto como Exhibit 99.1.

La información del Item 2.02 se está proporcionando y no se considera presentada conforme a la Exchange Act, y no está incorporada por referencia en presentaciones bajo la Securities Act. Las acciones ordinarias de la empresa cotizan como BLCO en la NYSE y en la Bolsa de Toronto.

Bausch + Lomb Corporation은 2025년 9월 30일 종료된 분기의 운영 실적을 발표하는 8-K를 제출했습니다. 상세 재무 정보는 Exhibit 99.1로 첨부된 보도자료에 제공됩니다.

Item 2.02 정보는 제공되며 Exchange Act에 따라 제출로 간주되지 않으며 Securities Act 제출에 의해 참조로 포함되지 않습니다. 회사의 보통주는 NYSE와 Toronto Stock Exchange에서 BLCO로 거래됩니다.

Bausch + Lomb Corporation a fourni un formulaire 8-K annonçant les résultats d'exploitation pour le trimestre clos le 30 septembre 2025. Les informations financières détaillées sont fournies dans un communiqué de presse joint sous le Exhibit 99.1.

Les informations de l'Item 2.02 sont fournies et ne sont pas considérées comme déposées en vertu de la Exchange Act, et elles ne sont pas incorporées par référence dans les dépôts sous la Securities Act. Les actions ordinaires de la société se négocient sous le symbole BLCO à la NYSE et à la Bourse de Toronto.

Bausch + Lomb Corporation hat eine 8-K eingereicht, die die betrieblichen Ergebnisse für das Quartal zum 30. September 2025 bekannt gibt. Die detaillierten Finanzinformationen sind in einer Pressemitteilung enthalten, die als Exhibit 99.1 beigefügt ist.

Die Informationen zu Item 2.02 werden bereitgestellt und gelten nicht als gemäß dem Exchange Act eingereicht, und sie sind nicht per Bezugnahme in Einreichungen gemäß dem Securities Act enthalten. Die Stammaktien des Unternehmens werden unter dem Symbol BLCO an der NYSE und an der Toronto Stock Exchange gehandelt.

Bausch + Lomb Corporation قدمت نموذج 8-K يعلن عن نتائج التشغيل للربع المنتهي في 30 سبتمبر 2025. Informationen المالية التفصيلية مقدمة في بيان صحفي مرفق كـ Exhibit 99.1.

يتم تزويد معلومات البند 2.02 ولا تعتبر مقدمة بموجب قانون التبادل، ولا يتم إدراجها بالإحالة في الإيداعات بموجب قانون الأوراق المالية. تُتداول أسهم الشركة العادية كـ BLCO في بورصة نيويورك وبورصة تورنتو.

Positive
  • None.
Negative
  • None.

Bausch + Lomb Corporation ha fornito un 8-K che annuncia i risultati operativi per il trimestre chiuso il 30 settembre 2025. Le informazioni finanziarie dettagliate sono fornite in un comunicato stampa allegato come Exhibit 99.1.

Le informazioni dell'Item 2.02 vengono fornite e non si ritengono presentate ai sensi della Exchange Act, e non sono incorporate per riferimento nei filing ai sensi del Securities Act. Le azioni ordinarie della società sono negoziate con il simbolo BLCO sulla NYSE e sulla Toronto Stock Exchange.

La Bausch + Lomb Corporation presentó un 8-K anunciando los resultados de operaciones para el trimestre terminado el 30 de septiembre de 2025. La información financiera detallada se ofrece en un comunicado de prensa adjunto como Exhibit 99.1.

La información del Item 2.02 se está proporcionando y no se considera presentada conforme a la Exchange Act, y no está incorporada por referencia en presentaciones bajo la Securities Act. Las acciones ordinarias de la empresa cotizan como BLCO en la NYSE y en la Bolsa de Toronto.

Bausch + Lomb Corporation은 2025년 9월 30일 종료된 분기의 운영 실적을 발표하는 8-K를 제출했습니다. 상세 재무 정보는 Exhibit 99.1로 첨부된 보도자료에 제공됩니다.

Item 2.02 정보는 제공되며 Exchange Act에 따라 제출로 간주되지 않으며 Securities Act 제출에 의해 참조로 포함되지 않습니다. 회사의 보통주는 NYSE와 Toronto Stock Exchange에서 BLCO로 거래됩니다.

Bausch + Lomb Corporation a fourni un formulaire 8-K annonçant les résultats d'exploitation pour le trimestre clos le 30 septembre 2025. Les informations financières détaillées sont fournies dans un communiqué de presse joint sous le Exhibit 99.1.

Les informations de l'Item 2.02 sont fournies et ne sont pas considérées comme déposées en vertu de la Exchange Act, et elles ne sont pas incorporées par référence dans les dépôts sous la Securities Act. Les actions ordinaires de la société se négocient sous le symbole BLCO à la NYSE et à la Bourse de Toronto.

Bausch + Lomb Corporation hat eine 8-K eingereicht, die die betrieblichen Ergebnisse für das Quartal zum 30. September 2025 bekannt gibt. Die detaillierten Finanzinformationen sind in einer Pressemitteilung enthalten, die als Exhibit 99.1 beigefügt ist.

Die Informationen zu Item 2.02 werden bereitgestellt und gelten nicht als gemäß dem Exchange Act eingereicht, und sie sind nicht per Bezugnahme in Einreichungen gemäß dem Securities Act enthalten. Die Stammaktien des Unternehmens werden unter dem Symbol BLCO an der NYSE und an der Toronto Stock Exchange gehandelt.

Bausch + Lomb Corporation قدمت نموذج 8-K يعلن عن نتائج التشغيل للربع المنتهي في 30 سبتمبر 2025. Informationen المالية التفصيلية مقدمة في بيان صحفي مرفق كـ Exhibit 99.1.

يتم تزويد معلومات البند 2.02 ولا تعتبر مقدمة بموجب قانون التبادل، ولا يتم إدراجها بالإحالة في الإيداعات بموجب قانون الأوراق المالية. تُتداول أسهم الشركة العادية كـ BLCO في بورصة نيويورك وبورصة تورنتو.

Bausch + Lomb Corporation 已提交一份8-K,宣布截至2025年9月30日的季度经营业绩。详细的财务信息载于作为 Exhibit 99.1 附上的新闻稿。

第2.02条信息正在提供,且不被视为根据《交易法》提交,也不通过引用并入《证券法》备案。公司的普通股在NYSE和多伦多证券交易所交易,代码为 BLCO

0001860742FALSEBausch & Lomb Corp00018607422025-10-292025-10-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
October 29, 2025
Date of Report (Date of the earliest event reported)
Bausch + Lomb Corporation
(Exact Name of Registrant as Specified in Its Charter)
Canada
001-41380
98-1613662
(State or Other Jurisdiction of
Incorporation or Organization)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
520 Applewood Crescent
Vaughan, Ontario
Canada L4K 4B4
(Address of Principal Executive Offices)(Zip Code)
(905) 695-7700
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Shares, No Par Value
BLCO
New York Stock Exchange
Toronto Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition.
On October 29, 2025, Bausch + Lomb Corporation (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2025 and certain other financial information as of and for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d)    Exhibits
Exhibit No.Description
99.1*
Press Release of Bausch + Lomb Corporation, respecting financial results for the third quarter of 2025, dated October 29, 2025
104*Cover Page Interactive Data File (formatted as Inline XBRL)
____________________________________
* Filed herewith.



Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BAUSCH + LOMB CORPORATION
By:
/s/ Sam Eldessouky
Name:Sam Eldessouky
Title:Executive Vice President, Chief Financial Officer
Date: October 29, 2025

FAQ

What did BLCO announce in its 8-K on October 29, 2025?

BLCO furnished a press release with financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.

Which period do the Bausch + Lomb results cover?

The results cover the quarter ended September 30, 2025.

Where can I find the detailed BLCO Q3 2025 results?

In the press release attached as Exhibit 99.1 to the 8-K.

Is the Item 2.02 information filed or furnished?

It is furnished and not deemed filed under the Exchange Act; it is not incorporated by reference into Securities Act filings.

What is the BLCO trading symbol and exchanges?

The common shares trade as BLCO on the NYSE and the Toronto Stock Exchange.

Who signed the 8-K for Bausch + Lomb?

It was signed by Sam Eldessouky, Executive Vice President and Chief Financial Officer.

Which 8-K item covers the BLCO earnings release?

Item 2.02 (Results of Operations and Financial Condition).
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

5.38B
41.93M
88.06%
11.29%
0.91%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN